Jeffreys Dover News Today

Since the epidermis overlying cNF is normal, "there is no reason to use nonselective or surgical methods and destroy a perfectly good epidermis when you dont need to," Patricia Richey, MD, said.

GuruFocus Article or News written by Business Wire and the topic is about:

Revance Reports Positive Efficacy and Duration Results from Phase 2 Upper Facial Lines Study Revance Reports Positive Efficacy and Duration Results from Phase 2 Upper Facial Lines Study Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, today announced positive topline efficacy and safety results from its Phase 2 multicenter, open-label study of investigational drug candidate DaxibotulinumtoxinA for Injection for the co...